US 6,274,706 B1 · Intron/exon of the human and mouse beta 3-adrenergic receptor genes

Abstract

The present invention relates to the intron and exon structure of the gene encoding β3 adrenergic receptor polypeptides of mouse and human origin, which polypeptides are useful in a procedure for studying the effects of various chemical agents on the β3 adrenergic receptor coupled to adenylate cyclase and hormone-sensitive lipases.

Claims1

Dependent claims

An isolated and purified polypeptide having β3-adrenergic receptor activity comprising the amino acid sequence of FIG. 4 (SEQ ID NO:6).

Dependencies are inferred from the claim text.

Facts

Application

08/450,962Filed 25 May 1995 · division

Priority

FR 890091825 Jan 1989

Granted

14 Aug 2001

Term ends

Not estimatedThe source records don’t support an estimate.

Classification5 codes

C07K 14/70571
Receptors; Cell surface antigens; Cell surface determinants: for neuromediators, e.g. serotonin receptor, dopamine receptor
C07K 16/286
Against receptors, cell surface antigens or cell surface determinants: against neuromediator receptors, e.g. serotonin receptor, dopamine receptor
A61K 38/00
Medicinal preparations containing peptides
C07K
Peptides

Family

Application07/721,571Parent of this continuation-in-part · filed 3 Sep 1991

Application08/117,829Parent of this division · filed 8 Sep 1993

Application08/117,829Parent of this continuation-in-part

US 5,288,607 AParent of this continuation-in-part

US 6,274,706 B1This patent

From the US filing history. Foreign family members aren’t listed.

Intron/exon of the human and mouse beta 3-adrenergic receptor genes

Life of this patent

Abstract

Claims1

Intron/exon of the human and mouse beta 3-adrenergic receptor genes

Life of this patent

Abstract

Claims1